This can be achieved by future studies utilizing techniques including siRNA to perform a specific knockdown of STIM1 and STIM2, which will enable researchers to identify the specific roles of these proteins in the TLR4-induced signaling of breast cancer cells. The gene discussed is TLR4; the disease is breast carcinoma.